RI-AF Score Calculator
Recurrent postoperative AF risk index
Enter the clinical and perioperative factors documented in the original study. The score updates automatically.
Risk bands reported by the publication: score below 9 = low; 10–22 = medium; above 22 = high. The publication does not specify a category for score 9.
About the recurrent postoperative AF index
Mathew and colleagues developed a multicenter risk index for atrial fibrillation after coronary artery bypass graft surgery and separately examined recurrent AF, defined as more than one episode during the index hospitalization. The recurrence model included patient history, age, perioperative medication withdrawal or use, and an intraoperative variable.
Important: This is a cardiac-surgery model. The source does not validate its use to predict recurrence after pacemaker or implantable cardioverter-defibrillator implantation.
Published predictor weights used here
| Predictor | Points |
|---|---|
| Age <40 / 40–49 / 50–59 / 60–69 / 70–79 / ≥80 years | +2 / +4 / +6 / +8 / +10 / +12 |
| History of CHF | −4 |
| LV hypertrophy | +5 |
| Moderate/severe aortic atherosclerosis | +5 |
| Bicaval cannulation | +4 |
| ACE inhibitor withdrawal | +6 |
| Beta-blocker withdrawal | +7 |
| Postoperative amiodarone | −7 |
| Postoperative digoxin | −6 |
Score bands in the source
Low risk: score <9. Medium risk: 10–22. High risk: >22. The original article does not define the category for a score of 9; the calculator flags this boundary rather than assigning an unsupported category.
Reference
PMID: 15082699
Model performance
The article reports an area under the ROC curve of 0.66 for the recurrent-AF model in the validation cohort, indicating limited discrimination. Results should be interpreted cautiously and within the population in which the model was developed.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.